Organicell Regenerative Medicine, Inc.
OCEL · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $11,338 | $11,230 | $11,230 | $11,215 |
| - Cash | $314 | $542 | $720 | $657 |
| + Debt | $119 | $102 | $11 | $13 |
| Enterprise Value | $11,143 | $10,790 | $10,521 | $10,571 |
| Revenue | $1,306 | $1,149 | $1,090 | $1,132 |
| % Growth | 13.7% | 5.4% | -3.7% | – |
| Gross Profit | $1,078 | $893 | $899 | $691 |
| % Margin | 82.5% | 77.7% | 82.5% | 61.1% |
| EBITDA | -$2,071 | -$1,394 | -$1,253 | -$828 |
| % Margin | -158.6% | -121.3% | -115% | -73.2% |
| Net Income | -$2,072 | -$1,391 | -$1,243 | $394 |
| % Margin | -158.7% | -121.1% | -114% | 34.8% |
| EPS Diluted | -0.32 | -0.22 | -0.2 | 0.062 |
| % Growth | -45.5% | -10% | -421.5% | – |
| Operating Cash Flow | -$257 | -$143 | $65 | -$535 |
| Capital Expenditures | -$23 | $0 | $0 | $9 |
| Free Cash Flow | -$280 | -$143 | $65 | -$526 |